Moneycontrol PRO
HomeNewsBusinessStocksMotilal Oswal neutral on Godrej Consumer

Motilal Oswal neutral on Godrej Consumer

Motilal Oswal has maintained neutral rating on Godrej Consumer Products (GCPL) with a target of Rs 740, in its October 8, 2012 research report.

October 09, 2012 / 12:24 IST

Motilal Oswal has maintained neutral rating on Godrej Consumer Products (GCPL) with a target of Rs 740, in its October 8, 2012 research report.

“GCPL’s strong run in HI market in India (44 % of domestic sales) continues unabated. Our analysis of the latest industry data points to continued share gains for GCPL (310bp market share gain during Dec 2011-Aug 2012). It is gaining share in every sub-segment of the HI category and improving its mix. We expect GCPL’s outperformance to continue on the back of (1) distribution synergies, (2) innovation, and (3) sustained brand spends. GCPL’s Soaps market share has remained flat for the last 12 months, but has started to pick up in last four months (Godrej No 1 up 40bp post Apr-12). The recent relaunch of Cinthol (with 10% price hike) should help boost GCPL’s Soaps performance, in our view. Channel checks indicate continued momentum in GCPL’s Soaps business in 2QFY13.”

“Softening of palm oil prices (down 23% in last 6 months in INR terms) is a positive for GCPL’s gross margins as palm oil is 20% of GCPL’s RMC. However, we expect the gains to flow in with a lag of 1-2 quarters, and also part passing-on of the cost savings via promotions. Recent currency appreciation is an additional positive given GCPL's USD 305m debt. We expect strong momentum to continue in GCPL’s international business led by Megasari (50% of international sales) and consolidation of Darling business. GCPL has demonstrated strong execution potential in the integration of its recently acquired businesses. Significant cross pollination potential still exists in categories like Hair Colors and HI, and successful execution of the same will be a key driver in the medium term.”

“We upgrade our FY13 and FY14 earnings estimates by 3-8% to factor in (a) market share gains in Home Insecticides, (b) softening of PFAD prices, and (c) margin improvements in international business in FY14 due to scale economies post integration. We now expect 32% EPS CAGR over FY12-14. Consequently, we revise our target price to INR740 (26x FY14E EPS). Maintain neutral,” says Motilal Oswal research report.

Public holding more than 90% in Indian cos

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment

first published: Oct 9, 2012 12:01 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347